Research Paper Volume 16, Issue 10 pp 8998—9022
Breast cancer clinical outcomes and tumor immune microenvironment: cross-dialogue of multiple epigenetic modification profiles
Figure 12. (A) Left: representative IHC images of ZMAT3 in breast cancer and the corresponding para-cancerous mammary duct. Scale bar = 20 μm. Right: the MOD values for the staining scores. (B) The correlations of MOD value of ZMAT3 with pathological grade (left) and clinical TNM stage (right), respectively. (C) Kaplan-Meier survival analysis for breast cancer patients with higher and lower expression levels of ZMAT3.